At first glance, the newest device from health-tech innovator PNOĒ looks straight out of a Hollywood blockbuster. The mask, which securely covers the nose and mouth before strapping firmly around the back of the head, bears more than a passing resemblance to the grim, mechanical facial gear worn by Bane, Batman’s hulking nemesis. Yet, despite its intimidating cinematic aesthetic, the device’s purpose is entirely benign. Designed to measure oxygen consumption and carbon dioxide exhalation with clinical precision, the apparatus translates complex respiratory data into actionable insights. It tells users how to eat, how to train, and—if the company’s ambitious vision holds true—how to live a longer, healthier life. As the wellness industry shifts its focus from superficial fitness tracking to deep biological longevity, PNOĒ is positioning itself at the vanguard of a quiet revolution. With a newly redesigned self-service model rolling out globally, the company aims to move metabolic testing out of elite research labs and into everyday fitness centers, hotel spas, and neighborhood pharmacies. 1. Main Facts: Decoding the PNOĒ 2.0 Ecosystem Based in Malden, Massachusetts, with primary operations anchored in Athens, Greece, PNOĒ is preparing for the official global launch of its flagship hardware update: the PNOĒ 2.0. The fundamental breakthrough of this iteration lies in its accessibility. Previous models required a trained clinical operator to administer the test, creating structural bottlenecks that limited where and when the assessments could take place. The 2.0 version changes the game entirely through self-administration. According to co-founder and CEO Apostolos Atsalakis, the user experience has been streamlined to absolute simplicity. A gym member can walk onto the floor, put on the mask, press a button on the companion software, sit down, and breathe normally for an eight-minute testing window. "That’s it. It’s that easy," Atsalakis explained during a recent video interview from the company’s Athens headquarters. Key Capabilities and Biomarkers The PNOĒ test captures 23 distinct metabolic and cardiorespiratory biomarkers through a single breath-by-breath analysis. Chief among these are: VO₂ Max: Widely recognized as the single strongest predictor of human longevity, measuring the maximum volume of oxygen an individual can utilize during intense exertion. Resting Metabolic Rate (RMR): Pinpointing the exact number of calories the body burns at complete rest, moving far beyond generic algorithmic estimates. Metabolic Flexibility: Evaluating how efficiently the human body switches between burning dietary fats and carbohydrates for fuel. By evaluating these metrics, PNOĒ provides objective answers to foundational health questions that standard blood tests simply cannot address—such as precise caloric requirements and personalized training zones. Hardware Innovation and Post-Pandemic Hygiene Designing a self-administered metabolic test from scratch was no small feat. PNOĒ partnered with Milan-based Design Group Italia to iterate the hardware repeatedly until it achieved commercial readiness. Crucially, the hardware addresses post-pandemic hygiene concerns head-on. The sensitive electronic sensors detach effortlessly from the medical-grade silicone mask and adjustable straps. This architectural split allows businesses to invest in high-end, shared electronic modules while individual users maintain absolute personal hygiene by keeping their own dedicated, low-cost masks. 2. Chronology: From Cambridge Labs to Global Scaling The journey of PNOĒ spans over a decade of scientific exploration, strategic pivots, and venture-backed growth. Academic Roots (Early 2010s): PNOĒ traces its origins to CEO Apostolos Atsalakis’s PhD research in sensing technologies at the University of Cambridge. Fascinated by the rich diagnostic data hidden within human respiration just as the wearable tech boom was taking off, Atsalakis laid the theoretical groundwork for the company. Founding and Incubation (2019): Atsalakis co-founded PNOĒ alongside his childhood friend, Panos Papadiamantis, who now serves as Chief Product Officer. The fledgling startup was accepted into Y Combinator’s Winter 2019 batch—a pivotal moment that occurred just before "longevity" exploded into a multi-billion-dollar cultural and economic phenomenon. Venture Capital Funding: Over the years, PNOĒ has successfully raised approximately $22 million in funding. This includes a recently closed $11 million financing round backed by prominent venture firms like 50 Years and angel investors such as Google Maps co-founder Lars Rasmussen, who is based in Athens. Commercial Expansion (Present Day): Today, PNOĒ operates on a pure B2B model, selling its testing apparatuses and software suites to elite athletic institutions, luxury hospitality brands, and high-end fitness chains. Approximately 85% of its business is concentrated in the United States, which Atsalakis describes as the most mature longevity market in the world, while the company rapidly expands its footprint across Europe, Latin America, and Asia. 3. Supporting Data: The Science of Longevity and Market Dynamics Metabolic testing itself is not a novel concept; the underlying science has existed for over a century. For decades, gas-exchange analysis has served as the gold standard for measuring cardiorespiratory fitness. However, traditional metabolic carts were bulky, expensive laboratory machines confined to university sports departments, elite training centers, and hospital cardiology wings. PNOĒ’s core disruption is miniaturization—delivering laboratory-grade accuracy in a portable, affordable format paired with automated software interpretation. The Rise of the Longevity Economy The timing of PNOĒ’s expansion aligns perfectly with a massive cultural shift toward preventative health and lifespan optimization. Backed by extensive epidemiological research linking high cardiorespiratory fitness (VO₂ max) to significantly lower all-cause mortality, consumers are increasingly obsessed with tracking their internal biological age. This has created a crowded middle ground in the wellness technology market: Consumer Wearables: Apple, Garmin, and Whoop continuously estimate VO₂ max using heart-rate variability and motion algorithms. Niche Competitors: Devices like Lumen analyze breath composition specifically to track daily fat-versus-carb burning. High-End Clinical Systems: Traditional metabolic carts remain entrenched in medical facilities for diagnostic pulmonary testing. PNOĒ sits uniquely between consumer wrist wearables and full clinical workups, offering diagnostic depth without the friction of a hospital visit. Business-in-a-Box Model PNOĒ sells its solutions exclusively to businesses via a recurring subscription model ranging from $400 to over $1,000 per month. This subscription functions as a complete "business in a box," encompassing the hardware, diagnostic software, staff training modules, and co-branded marketing materials. The commercial impact for clients is direct. Gyms, med spas, and hotels use the PNOĒ assessment during client onboarding. By integrating test results directly into their ecosystem, businesses can automatically recommend specific personal training packages, dietary plans, or spa therapies tailored to the user’s precise metabolic profile. Current clients read like a roster of elite wellness and athletic organizations: Equinox (available in almost all club locations) Four Seasons Hotels & Resorts Red Bull Athlete Performance Centers National Basketball Association (NBA) teams Mount Sinai Health System Restore Hyper Wellness 4. Official Responses: Regulatory Stance and Future Horizons Despite its clinical-sounding capabilities, PNOĒ maintains a strict boundary regarding its regulatory classification. The device has not received clearance from the U.S. Food and Drug Administration (FDA), and company leadership is explicit about its intended scope. "We do not provide medical recommendations," CEO Apostolos Atsalakis emphasized. "It’s like a body composition device, like a scale. A doctor cannot prescribe medication based on our results." Instead, PNOĒ positions itself firmly within the wellness and fitness sector, drawing comparisons to standard smart scales or body-fat analyzers. This strategic choice allows the company to scale rapidly across commercial fitness and hospitality markets without becoming bogged down by the arduous, multi-year FDA approval cycles required for medical diagnostic tools. The Road to Clinical Diagnostics Looking further ahead, however, Atsalakis acknowledges that breath analysis holds profound potential for mainstream medicine. Medical researchers have long studied volatile organic compounds in human respiration as potential early warning indicators for oncology, metabolic diseases, and pulmonary disorders. While Atsalakis believes that PNOĒ’s expanding repository of respiratory data could eventually aid in early health issue detection, he remains grounded about the timeline. Full diagnostic capabilities are "definitely a couple of years away," heavily dependent on navigating complex international regulatory frameworks. "We’re not there yet," he noted. 5. Implications: Profitability, Scaling, and the Path Forward The financial health of PNOĒ mirrors its technological ambition. The 110-person company has recently achieved overall profitability, boasting year-over-year revenue growth exceeding 100%. Buoyed by this commercial momentum, Atsalakis revealed that PNOĒ plans to raise a formal Series B funding round within the next six to twelve months. The capital will fuel further international expansion, software development, and hardware refinement as the company strives to place its iconic mask—Bane comparisons and all—in front of millions of new faces worldwide. As the boundary between fitness tracking and biological health monitoring continues to blur, PNOĒ’s self-service metabolic testing model suggests that the future of wellness may no longer require a trip to a hospital lab. Instead, the keys to a longer life may be waiting right at your local gym, unlocked by a simple, eight-minute breath test. Post navigation The Battle for AI Search Supremacy: A Comprehensive Analysis of Scrunch vs. Peec AI in the Era of Answer Engine Optimization Beyond the Algorithm: How Radical Content Innovation is Redefining Brand Engagement
